Terapias inovadoras em modelo experimental de hipóxia-isquemia neonatal : neuropeptídeo nap e células mononucleares de sangue de cordão umbilical humano

• Autor(a) principal: Greggio, Samuel
• Data de Publicação: 2013
• Tipo de documento: Tese
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da PUC_RS
• Texto Completo: http://tede2.pucrs.br/tede2/handle/tede/1410
• topic: MEDICINA; PEDIATRIA; HIPÓXIA ENCEFÁLICA; CORDÃO UMBILICAL; NEONATOLOGIA; MEMÓRIA; CNPQ::CIENCIAS DA SAUDE::MEDICINA

Objectives: to investigate separately the therapeutic potential of neuropeptide NAP and the intra-arterial (IA) transplantation of human umbilical cord blood (HUCB) mononuclear cells in an animal model of neonatal hypoxia-ischemia (HI). Methods: male Wistar rats at postnatal day 7 were subjected to an HI model by permanent occlusion of right common carotid artery and systemic hypoxia (8% O2 for 2 h). The animals were randomly assigned to groups receiving an intraperitoneal injection of NAP (3 μg/g) immediately (0 h) and 24 h after HI. Other animals received HUCB mononuclear cells (1 x 106 or 1 x 107 cells/50 μL) into the left common carotid artery 24 h after HI insult by using the microneedle technique. Only for NAP study, brain DNA damage, lipid peroxidation and reduced glutathione (GSH) content were determined 48 h post-HI insult. The spatial version of the Morris water maze learning task and the stereological volume assessment were performed in adult animals that received both therapies. The accelerated rotarod test and cerebral and body weight determination were applied only for cellular therapy study. The HUCB mononuclear cells migration was monitored through nested-PCR analysis in the brain and systemic organs of transplanted-HI rats. Results: we observed that NAP prevented the acute HI-induced DNA and lipid membrane damage and also recovered the GSH levels in the injured hemisphere of the HI rat pups. Further, NAP was able to hinder impairments in learning and long-term spatial memory and to significantly reduce brain damage in adult animals previously subjected to neonatal HI. The IA transplantation in neonatal HI rat seemed to be a feasible and safe delivery route for HUCB mononuclear cells. The intra-arterially delivered cells hindered dose-dependently the learning and spatial memory impairments without brain damage recovery in adult rats. Additionally we further showed that HI insult or IA cell transplantation had no long-term impact in the body weight and motor function in rodents. The HUCB mononuclear cells could be promptly identified in the ischemic brain after IA transplantation and also in some peripheral organs until at least 30 days later. Conclusions: the viability and long-lasting beneficial effects of neuropeptide NAP and IA transplantation of HUCB mononuclear cells support its translational characteristic for neonatal HI management. Therefore, NAP and intracarotid delivery of cells became promising candidates for the treatment of HI-induced brain damage and life-long disabilities